Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Otto

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Pain|February 23, 2010
Anti-GD(2) with an FC point mutation reduces complement fixation and decreases antibody-induced allodyniaLinda S Sorkin, Mario Otto, William M Baldwin, et al.
Journal of the American Chemical Society|August 11, 2011
Leading neuroblastoma cells to die by multiple premeditated attacks from a multifunctionalized nanoconstructPeifu Jiao, Hongyu Zhou, Mario Otto, et al.
Molecular Imaging and Biology|June 12, 2019
[<sup>124</sup>I]CLR1404 PET/CT in High-Grade Primary and Metastatic Brain TumorsLance T Hall, Benjamin Titz, Nishanta Baidya, et al.
American Journal of Cancer Research|January 26, 2016
Tumor-selective anti-cancer effects of the synthetic alkyl phosphocholine analog CLR1404 in neuroblastomaRoberta Marino, Dana C Baiu, Saswati Bhattacharya, et al.
Blood|September 11, 2004
Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patientsXiaohua Chen, Raymond Barfield, Ely Benaim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2017
Targeted Molecular Radiotherapy of Pediatric Solid Tumors Using a Radioiodinated Alkyl-Phospholipid Ether AnalogDana C Baiu, Ian R Marsh, Alexander E Boruch, et al.
Molecular Cancer Therapeutics|August 16, 2018
Enhanced Radiosensitivity in Solid Tumors using a Tumor-selective Alkyl Phospholipid Ether AnalogMohamed Y Elsaid, Ankita Shahi, Albert R Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastomaFariba Navid, Paul M Sondel, Raymond Barfield, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Pain|February 23, 2010
Anti-GD(2) with an FC point mutation reduces complement fixation and decreases antibody-induced allodyniaLinda S Sorkin, Mario Otto, William M Baldwin, et al.
Journal of the American Chemical Society|August 11, 2011
Leading neuroblastoma cells to die by multiple premeditated attacks from a multifunctionalized nanoconstructPeifu Jiao, Hongyu Zhou, Mario Otto, et al.
Molecular Imaging and Biology|June 12, 2019
[<sup>124</sup>I]CLR1404 PET/CT in High-Grade Primary and Metastatic Brain TumorsLance T Hall, Benjamin Titz, Nishanta Baidya, et al.
American Journal of Cancer Research|January 26, 2016
Tumor-selective anti-cancer effects of the synthetic alkyl phosphocholine analog CLR1404 in neuroblastomaRoberta Marino, Dana C Baiu, Saswati Bhattacharya, et al.
Blood|September 11, 2004
Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patientsXiaohua Chen, Raymond Barfield, Ely Benaim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2017
Targeted Molecular Radiotherapy of Pediatric Solid Tumors Using a Radioiodinated Alkyl-Phospholipid Ether AnalogDana C Baiu, Ian R Marsh, Alexander E Boruch, et al.
Molecular Cancer Therapeutics|August 16, 2018
Enhanced Radiosensitivity in Solid Tumors using a Tumor-selective Alkyl Phospholipid Ether AnalogMohamed Y Elsaid, Ankita Shahi, Albert R Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastomaFariba Navid, Paul M Sondel, Raymond Barfield, et al.
Pageof 3